ELEDON PHARMACEUTICALS INC (ELDN)
US28617K1016 - Common Stock
ELDN Stock Earnings: Eledon Pharma Beats EPS for Q4 2023
ELDN stock results show that Eledon Pharma beat analyst estimates for earnings per share the fourth quarter of 2023.
ELDN Stock Earnings: Eledon Pharma Beats EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Eledon Pharma (NASDAQ:ELDN) just reported results for the fourth quarter of 202...
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results ...
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection...
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human...
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...
Eledon Pharmaceuticals reports recent business milestones (NASDAQ:ELDN)
Eledon Pharmaceuticals reports positive data from Phase 1b trial in kidney transplantation, highlighting the success and safety of tegoprubart.
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook...
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference...
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results ...
Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference
Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference
Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference...
Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation...
Second person to get pig heart transplant dies
"As with the first patient, David Bennett, we intend to conduct an extensive analysis to identify factors that can be prevented in future transplants," said Muh
Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer
Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer
Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer...
Eledon Pharmaceuticals to Present Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Society of Nephrology Kidney Week 2023 Annual Meeting
Eledon Pharmaceuticals to Present Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at Kidney Week 2023...
Eledon Pharmaceuticals Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors
Eledon Pharmaceuticals Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors
Eledon Pharmaceuticals Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors...
Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human
Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human
Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human...
Eledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference
Eledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference
IRVINE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that David-Alexandre C. Gros,...
Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors
Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors
IRVINE, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced the appointment of James...